# iSpecimen (ISPC) — News

ISPC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ispc/news

## Recent headlines

- [Ispecimen - Deal valued at $4.50 mln: $2 mln cash, $2.50 mln in common stock - SEC filing](https://www.ainvest.com/news/ispecimen-deal-valued-4-50-mln-2-mln-cash-2-50-mln-common-stock-sec-filing-2609) — AInvest Wire, Sep 4, 2026
  A recent SEC filing reveals that Ispecimen has entered into a business transaction valued at $4.50 million, with $2 million in cash and $2.50 million in common stock as part of the agreement[1]. The filing, made public on September 4, 2026, provides details about the structure of the deal but does…
- [Ispecimen - To buy AI software and models including disease trend prediction AI model - SEC filing](https://www.ainvest.com/news/ispecimen-buy-ai-software-models-including-disease-trend-prediction-ai-model-sec-filing-2609) — AInvest Wire, Sep 4, 2026
- [Ispecimen - Enters asset purchase agreement with FoldLab AI on Sept 4, 2026 - SEC filing](https://www.ainvest.com/news/ispecimen-enters-asset-purchase-agreement-foldlab-ai-sept-4-2026-sec-filing-2609) — AInvest Wire, Sep 4, 2026
  On September 4, 2026, iSpecimen Inc. disclosed an asset purchase agreement with FoldLab AI, as reported in a recent SEC filing. The transaction, detailed in a Form 8-K filed with the U.S. Securities and Exchange Commission, outlines the terms under which iSpecimen will acquire certain assets from…
- [Ispecimen - Appoints Shahin Behroyan as chief executive officer effective August 26, 2026 - SEC filing](https://www.ainvest.com/news/ispecimen-appoints-shahin-behroyan-chief-executive-officer-effective-august-26-2026-sec-filing-2609) — AInvest Wire, Aug 31, 2026
  Ispecimen has announced the appointment of Shahin Behroyan as its chief executive officer, effective August 26, 2026, as disclosed in a recent SEC filing [1]. The transition marks a strategic leadership change for the company as it continues to navigate its operational and financial objectives. No…
- [Ispecimen - On August 26, Katharyn Field to transition from role as chief executive officer - SEC filing](https://www.ainvest.com/news/ispecimen-august-26-katharyn-field-transition-role-chief-executive-officer-sec-filing-2609) — AInvest Wire, Aug 31, 2026
  On August 26, 2026, Katharyn Field announced her transition from the role of chief executive officer at Ispecimen, as disclosed in a recent SEC filing [1]. The filing outlines the executive change without providing further details on the reasons for the transition or the identity of Field’s…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).